Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

Subscription Publication, 7.57M), the Los Angeles Times (10/22, Haberkorn, 4.64M), the Washington Times (10/22, Swoyer, 492K), the Fox News (10/22, McFall, 27.59M) website, and The Hill (10/22, Carney, 2.98M) are among the other sources covering the vote. Trump Plans To Nominate Kirsch To Barren's Sev

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

2K), the Fox News <https://www.foxnews.corn/politics/senate-leadership-exchange-angry- jibes-following-the-vote-to-advance-amy-coney-barrett> (10/22, McFall, 27.59M) website, and The Hill <hftps://thehill.corn/homenews/senate/522216-gop-advances-barretts-supreme-court-nomination-after-dems- boycott-commi

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

Subscription Publication, 7.57M), the Los Angeles Times (10/22, Haberkorn, 4.64M), the Washington Times (10/22, Swoyer, 492K), the Fox News (10/22, McFall, 27.59M) website, and The Hill (10/22, Carney, 2.98M) are among the other sources covering the vote. Trump Plans To Nominate Kirsch To Barrett's Se